Literature DB >> 3392667

Enkephalin hyperpolarizes interneurones in the rat hippocampus.

D V Madison1, R A Nicoll.   

Abstract

1. Intracellular recordings were made from pyramidal cells and from electrophysiologically identified interneurones in the CA1 region of the hippocampal slice preparation from the rat. 2. Enkephalin blocked the hyperpolarization of pyramidal cells evoked by application of glutamate to synaptically coupled inhibitory interneurones. 3. Enkephalin hyperpolarized interneurones, most probably by increasing potassium conductance; this action was blocked by the opiate antagonist, naloxone. 4. Activation of gamma-aminobutyric acid(B) receptors with baclofen in interneurones produced a similar hyperpolarization that was resistant to naloxone. 5. In addition to hyperpolarizing interneurones, enkephalin blocked the inhibitory postsynaptic potential recorded in these cells. 6. These results suggest that opiate receptors are selectively localized on inhibitory interneurones in the hippocampus and are coupled to potassium channels. Activation of these receptors causes a disinhibition of both pyramidal cells and inhibitory interneurones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392667      PMCID: PMC1191763          DOI: 10.1113/jphysiol.1988.sp017033

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

Authors:  A W Mudge; S E Leeman; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study.

Authors:  R A Nicoll; G R Siggins; N Ling; F E Bloom; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons.

Authors:  W Zieglgänsberger; E D French; G R Siggins; F E Bloom
Journal:  Science       Date:  1979-07-27       Impact factor: 47.728

4.  Enkephalin blocks inhibitory pathways in the vertebrate CNS.

Authors:  R A Nicoll; B E Alger; C E Jahr
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

5.  Enkephalin opens potassium channels on mammalian central neurones.

Authors:  J T Williams; T M Egan; R A North
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

6.  Opiate activation of potassium conductance in myenteric neurons: inhibition by calcium ion.

Authors:  K Morita; R A North
Journal:  Brain Res       Date:  1982-06-17       Impact factor: 3.252

7.  A simple chamber for recording from submerged brain slices.

Authors:  R A Nicoll; B E Alger
Journal:  J Neurosci Methods       Date:  1981-08       Impact factor: 2.390

8.  Local circuit synaptic interactions in hippocampal brain slices.

Authors:  W D Knowles; P A Schwartzkroin
Journal:  J Neurosci       Date:  1981-03       Impact factor: 6.167

9.  Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. II. Effects on interneuron excitability.

Authors:  H K Lee; T Dunwiddie; B Hoffer
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

10.  Opiate- and alpha 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3':5'-monophosphate analogues.

Authors:  R Andrade; G K Aghajanian
Journal:  J Neurosci       Date:  1985-09       Impact factor: 6.167

View more
  60 in total

1.  Self-organized synaptic plasticity contributes to the shaping of gamma and beta oscillations in vitro.

Authors:  A Bibbig; H J Faulkner; M A Whittington; R D Traub
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  Visualization of the distribution of autophosphorylated calcium/calmodulin-dependent protein kinase II after tetanic stimulation in the CA1 area of the hippocampus.

Authors:  Y Ouyang; D Kantor; K M Harris; E M Schuman; M B Kennedy
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

4.  Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

Authors:  D R Cleary; M J Neubert; M M Heinricher
Journal:  Neuroscience       Date:  2007-11-04       Impact factor: 3.590

5.  Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway.

Authors:  Annelyn Torres-Reveron; Sana Khalid; Tanya J Williams; Elizabeth M Waters; Carrie T Drake; Bruce S McEwen; Teresa A Milner
Journal:  Brain Res       Date:  2008-07-26       Impact factor: 3.252

6.  Mu-Opioids Suppress GABAergic Synaptic Transmission onto Orbitofrontal Cortex Pyramidal Neurons with Subregional Selectivity.

Authors:  Benjamin K Lau; Brittany P Ambrose; Catherine S Thomas; Min Qiao; Stephanie L Borgland
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

7.  Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents.

Authors:  K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

8.  Epileptiform synchronization in the cingulate cortex.

Authors:  Gabriella Panuccio; Giulia Curia; Alfredo Colosimo; Giorgio Cruccu; Massimo Avoli
Journal:  Epilepsia       Date:  2008-10-30       Impact factor: 5.864

9.  Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro.

Authors:  M Capogna; B H Gähwiler; S M Thompson
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

10.  Bicuculline-resistant paired-pulse inhibition in the rat hippocampal slice.

Authors:  M J Higgins; T W Stone
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.